ArticleJournal of lipid research2009

The synergistic inhibition of atherogenesis in apoE-/- mice between pravastatin and the sPLA2 inhibitor varespladib (A-002).

Zory Shaposhnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.